drug · small molecule
(dexborneol + edaravone)
Phase 3updated 3mo agoby Simcere Pharmaceutical Group Ltd🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for axial length measurement and amyotrophic lateral sclerosis and 6 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying (dexborneol + edaravone)
- phase2Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL
- phase4Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke
- phase2Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
- —Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
- phase3Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that